<DOC>
	<DOCNO>NCT01188356</DOCNO>
	<brief_summary>The purpose study evaluate incidence evolution over-time co-morbidities general dual-chamber pacemaker population ( n=2188 patient ) 2 year follow-up .</brief_summary>
	<brief_title>EMERALD - AssEssment CoMorbidities &amp; Atrial ArRhythmiA Burden DuaL-Chamber PaceD Patients</brief_title>
	<detailed_description>The study focus number patient move persistent Atrial Fibrillation function cumulative % Vp ( &lt; &gt; 40 % ) , general dual-chamber pacemaker population 2 year follow-up ( n=2188 ) . The endpoint analyze sub population ( Sinus Node Disease AVB ) 4 year follow ( n=4290 ) .</detailed_description>
	<criteria>Patient implant ( primoimplant , replacement , upgrade ) dual chamber pacemaker less two month implant inclusion . Contraindicated cardiac pacing , accord ESC ACC/AHA/HRS guideline Permanent persistent atrial tachyarrhythmia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Reply</keyword>
	<keyword>Symphony</keyword>
	<keyword>Atrial arrhythmia</keyword>
	<keyword>V pacing</keyword>
	<keyword>Evaluate incidence evolution over-time co-morbidities</keyword>
</DOC>